Transplant Diagnostics Market worth $645.0 Million by 2019

The report “Transplant Diagnostics Market by Technology (Serological, SSO- & SSP-PCR, Sanger Sequencing, NGS), Product (Instrument, Reagent, Software), End User (Hospitals, Transplant Centers, Academia), Application (Diagnostic, Research) - Global Forecasts to 2019”, the global transplant diagnostics market is poised to grow at a CAGR of 6.5% during 2014-2019, and is expected to reach a value of $645.0 Million in 2019.

Browse 79 market data tables and 56 figures spread through 180 pages and in-depth TOC on “Transplant Diagnostics Market"

Early buyers will receive 10% customization on this report.


On the basis of type of technology, the global transplant diagnostics market has been divided into two major segments, namely, molecular and non-molecular assay technology. The molecular assay technology segment accounted for the largest share of the global market in 2014. Furthermore, molecular assay technology segment is expected to grow at the highest CAGR in the next five years, owing to factors such as development of innovative HLA typing products, benefits offered by robotics in lab automation, increasing installation base of PCR and NGS instruments, and high growth opportunities in emerging markets (such as Asia and Latin America).


On the basis of type of application, the global market is classified into diagnostic applications and research applications. The diagnostic application segment accounted for the largest share of the global transplant diagnostics market in 2014, and is expected to grow at the highest CAGR in the next five years, owing to rising number of solid organ and bone marrow transplantation procedure across the globe, growing application base of HLA typing products in clinical diagnosis, and market growth in emerging countries due to rapidly modernizing healthcare infrastructure.


Get The PDF Brochure for This Report@


A number of factors such as growing geriatric population, coupled with an increasing population base for chronic disease patients, technological advancement in the field of HLA typing, increased public-private investments to develop innovative HLA testing products, rising number of solid organ, soft tissue, and stem cell-based transplantation procedures across the world are propelling the growth of global transplant diagnostics market. However, factors such as high cost of PCR and NGS instruments and limited medical reimbursement available for transplantation procedures across the globe are restraining the growth of this market. Huge gap between organs donated and organ transplantation required annually is negatively affecting the growth of this market.


On the basis of geography, global market is classified into four regions, namely, North America, Europe, Asia-Pacific, and Rest of the World. In 2014, the global transplant diagnostics market was dominated by North America. A number of factors such as increase in public and private funding for development of HLA typing technology, growing number of solid organ transplantation procedure, and continuous reduction in average cost of gene sequencing are driving the growth of this market in the North American region. However, the Asia-Pacific market is expected to grow at the highest CAGR from 2014 to 2019 due to factors such as increasing focus of global life science companies in emerging markets, growing public and private support to develop novel HLA typing technologies, and strengthening healthcare infrastructure across the region.


New product launches and product developments are the key strategies adopted by the major players to develop their position in this global market. Moreover, strategies such as geographic expansions, partnerships, agreements, collaborations, and acquisitions were also adopted by a significant number of market players to strengthen their product portfolio and to expand their geographic presence in the transplant diagnostics market.


Get The Sample Copy Of This Report:


Abbott Laboratories Inc. (U.S.), Bio-Rad Laboratories Inc. (U.S.), F. Hoffmann-La Roche, Ltd. (Switzerland), Illumina, Inc. (U.S.), Immucor, Inc. (U.S.), Linkage Biosciences (U.S.), Olerup Ssp Ab (Norway), Qiagen N.V. (Netherlands), Sigma-Aldrich (U.S.), and Thermo Fisher Scientific Inc. (U.S.) are the key players operating in the global transplant diagnostics market.


Browse Related Reports:

Molecular Diagnostics Market by Application (Infectious Disease, Oncology, Genetics, Microbiology), Technology (PCR, INAAT, DNA Sequencing), End User (Hospital, Laboratories), Product (Instruments, Reagent, Service, Software) - Global Forecasts to 2018.


In Vitro Diagnostic (IVD) Market [Instruments, Reagents & Data Management Systems] [Technique (Immunoassay, Clinical Chemistry, Molecular Diagnostics, Haematology) & Applications (Diabetes, Infectious Diseases, Cancer & Cardiology)] Systems, End Users] - Forecast To 2017.


About MarketsandMarkets:

MarketsandMarkets is world’s No. 2 firm in terms of annually published premium market research reports. Serving 1700 global fortune enterprises with more than 1200 premium studies in a year, M&M is catering to multitude of clients across 8 different industrial verticals. We specialize in consulting assignments and business research across high growth markets, cutting edge technologies and newer applications. Our 850 fulltime analyst and SMEs at MarketsandMarkets are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors.


M&M’s flagship competitive intelligence and market research platform, "RT" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets. The new included chapters on Methodology and Benchmarking presented with high quality analytical infographics in our reports gives complete visibility of how the numbers have been arrived and defend the accuracy of the numbers.


We at MarketsandMarkets are inspired to help our clients grow by providing apt business insight with our huge market intelligence repository.


Subscribe Reports from Healthcare Domain @


Mr. Rohan

Unit No. 802, 8th Floor, 

Tower - 7, Magarpatta City SEZ,

Hadapsar, Pune – 411013, 

Maharashtra, India.

Tel: +1-888-6006-441.

Visit MarketsandMarkets Blog @

Connect with us on LinkedIn @